Ledger.Open graph →
SEC Form D · filed February 24, 2010

Eleven Biotherapeutics, Inc

Offering
$35.0M
Sold
$4.5M
Exemption
—
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

People & firms on this filing (8)

Mark Levin · Boston, MAExec · DirectorCary Pfeffer · Cambridge, MAExec · DirectorKim C. Drapkin · Cambridge, MAExecMark Levin · Rockville, MDExec · DirectorDavid M. Berry · Cambridge, MADirectorNoubar B. Afeyan · Cambridge, MADirectorCary Pfeffer · Boston, MAExec · DirectorKim C. Drapkin · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗